Seviteronel
Seviteronel (VT-464) is a dual-action investigational agent, functioning as both a CYP17 lyase inhibitor and an androgen receptor antagonist. It is utilized in preclinical and clinical research for hormone-driven cancers, including studies in castration-resistant prostate cancer and androgen receptor-positive breast cancer models.
Product Specifications
CAS Number
1610537-15-9
Product Name Alternative
H-CYP17 Lyase, CYP17, Androgen Receptor, AndrogenReceptor, Seviteronel, VT 464, VT464, VT-464
Field of Research
Metabolism Research
Purity
99.67% (May vary between batches)
Solubility
DMSO:40 mg/mL (100.17 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.01 mM)
Smiles
CC (C) [C@@] (O) (c1c[nH]nn1) c1ccc2cc (OC (F) F) c (OC (F) F) cc2c1
Molecular Formula
C18H17F4N3O3
Molecular Weight
399.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS584087-01 0.1 mg
Mouse Anti-Human Beta-3 integrin subunit Monoclonal Antibody
Sign In for Pricing
View Details MBS584087-02 5x 0.1 mg
Mouse Anti-Human Beta-3 integrin subunit Monoclonal Antibody
Sign In for Pricing
View Details